Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON) And E I Du Pont De Nemours And Co (DD) Have Spent $8 Million This Week To Defeat GMO Labeling Law In Washington

This November voters in Washington will be deciding on labeling of genetically modified foods via Washington Initiative 522, and thus far the biotech/agribusiness industry is coming out swinging spending millions in less than a week to defeat the measure. Monsanto Company (NYSE:MON) has spent $4.5 million this week while E I Du Pont De Nemours And Co (NYSE:DD) has shoveled another $3.25 million into the battle. Combine this with $500,000 spent by Bayer a few weeks ago and you can see that the industry isn’t taking this lightly.

Monsanto Company (NYSE:MON)

One can expect the spending to increase dramatically as Monsanto Company (NYSE:MON) and its cohorts have fought hard to water down a GMO labeling bill in Connecticut and recently spent over $50 million to defeat GMO labeling in California. What makes the full on media blitz and dollars spent to stop these laws curious is that polls show the vast majority of Americans are in fact in favor of required labeling for genetically modified foods. A recent poll from the New York Times returned results showing 93% of respondents wanted GMOs identified. The recent sustained selling in Monsanto Company (NYSE:MON)’s stock has even led many to believe hedge funds are growing weary of the increasing battles against modified crops.

Floating Path explores economic and cultural phenomena, and hopes to educate, inspire and provoke. Discover their wide range of daily content here.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.